Vincent Vultaggio serves as PAO and PFO at Zentalis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Vincent Vultaggio has executed 6 insider transactions totaling $105.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 10, 2026 involved selling 6,894 shares valued at $16.7K.
Vincent Vultaggio currently holds 146,506 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $0. This represents their equity stake as PAO and PFO.
Based on SEC Form 4 filings, Vincent Vultaggio has been a net seller of ZNTL stock. They have purchased $0 and sold $105.4K worth of shares.
Vincent Vultaggio's most recent insider trade was on Feb 10, 2026, when they sold 6,894 shares at $2.42 per share.
Get notified when new Form 4 filings are submitted
| $2.39 |
| Discretionary |
| Feb 6, 2026 | ZNTL | $72.8K | Sale | 29,951 | $2.43 | Discretionary |
| Feb 3, 2026 | ZNTL | $1.4K | Sale | 556 | $2.52 | Discretionary |
| Feb 2, 2026 | ZNTL | $6.5K | Sale | 2,540 | $2.55 | Discretionary |
| Jan 8, 2026 | ZNTL | $0 | Award | 100,000 | $N/A | Discretionary |